ArticleThrombosis journal2013
New oral anticoagulants: discussion on monitoring and adherence should start now!
Article in Thrombosis journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Efficacy and safety of direct oral anticoagulants and low molecular weight heparin for cancer-associated venous thromboembolism in patients with extremes in bodyweight.Journal of thrombosis and thrombolysis · 2026Article
- A Real-World, Prospective, Observational Study of Rivaroxaban on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-Valvular Atrial Fibrillation: XARENAL.Korean circulation journal · 2025Article
- Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.European heart journal. Cardiovascular pharmacotherapy · 2021Review
- The relationship between DOAC levels and clinical outcomes: The measures tell the tale.Journal of thrombosis and haemostasis : JTH · 2020Article
- Direct oral anticoagulants: a review of common medication errors.Journal of thrombosis and thrombolysis · 2019Review
- Associations between illness beliefs, medication beliefs, anticoagulation-related quality of life, and INR control: Insights from the Switching Study.Research and practice in thrombosis and haemostasis · 2018Article
- Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.European journal of clinical pharmacology · 2018Article
- Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital setting.Therapeutic advances in drug safety · 2018Article
- Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy.Stroke · 2017Article
- Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.The patient · 2017Review
- Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants.Journal of geriatric cardiology : JGC · 2016Article
- The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency.Scientific reports · 2016Article
- Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.European heart journal supplements : journal of the European Society of Cardiology · 2016Article
- Once-daily rivaroxaban for long-term stroke prevention in patients with atrial fibrillation.European heart journal supplements : journal of the European Society of Cardiology · 2016Article
- Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.BMC cardiovascular disorders · 2015Article
- Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offs.Thrombosis journal · 2015Article
- Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations.BioMed research international · 2015Review
- Preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants.BioMed research international · 2014Article
- Search For The Ideal Antithrombotic Drug: Utopian Task Likely Is Implemented Already.Journal of atrial fibrillationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New oral anticoagulants (NOACs) have been introduced to improve anticoagulant therapy worldwide, but safe implementation may require additional measures. First, optimization of dose adjustment based on therapeutic levels of the drug may be more appropriate than fixed dose therapy. The development and implementation in quantitative laboratory assays will enable further dose optimization. Second, non-adherence to medication is a potential threat to the safe use of NOACs. Since cardiovascular medication may not be optimally used in about 50% of patients, procedures to improve adherence are imperative, also for NOAC therapy and in particular in elderly patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.